ZBNA
AGIO icon

Zions Bancorporation, National Association’s Agios Pharmaceuticals AGIO Stock Holding History

Zions Bancorporation, National Association’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41K Buy
+38
New +$1.15K ﹤0.01% 1359

Other funds holding AGIO

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Zions Bancorporation, National Association's AGIO Position: Q2 2026 in Review

Zions Bancorporation, National Association opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 38 shares worth $1.41K. The stake represents ﹤0.01% of the portfolio and ranks #1359 among its holdings.

41 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Zions Bancorporation, National Association held 38 shares of Agios Pharmaceuticals worth $1.41K as of Q2 2026.
  • Agios Pharmaceuticals was a new Zions Bancorporation, National Association position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1359 holding.
  • 41 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.